Is Lusutrombopag included in medical insurance in China?

Lusutrombopag is an oral thrombopoietin receptor agonist, mainly used to prevent thrombocytopenia in patients with chronic liver disease before invasive surgery or procedures. The drug reduces the risk of surgical bleeding and improves patient safety by stimulating megakaryocytes in the bone marrow to produce platelets. After being launched in China, Rutrombopag tablets have provided a convenient, safe and effective platelet management solution for clinical use.

In the Chinese market, Rutrombopag tablets have been included in the scope of medical insurance reimbursement. This means that when eligible patients purchase the drug in the hospital, part of the cost can be reimbursed through medical insurance, thereby reducing the financial burden of treatment. The specific reimbursement ratio varies by region. Patients should consult their hospital or medical insurance department for the latest policies before use to ensure they understand the reimbursable amount and reimbursement process so that they can reasonably arrange their medication plan.

The domestic market price of Rutrombopag tablets is approximately RMB 3,000 to 4,000 per box. The specific price is based on the actual selling price in hospital pharmacies. For patients, with the support of medical insurance reimbursement, the economic pressure of the drug is relatively controllable, and it can be used more safely for platelet management and related treatments before surgery. At the same time, patients should strictly follow the doctor's prescription and avoid adjusting the dosage or medication cycle on their own to ensure efficacy and medication safety.

In overseas markets, there are also generic versions of Rutrombopag on the market. For example, the generic version produced by Lucius in Laos sells for about more than 1,000 yuan per box. The ingredients of this generic drug are basically the same as those of the original drug, providing a viable option for patients with limited financial conditions. Whether it is a domestic original drug or an overseas generic drug, patients should purchase and use it through formal channels to ensure drug quality and safety, and at the same time use it rationally under the guidance of a doctor to achieve the best therapeutic effect.

Reference materials:https://en.wikipedia.org/wiki/Lusutrombopag